Literature DB >> 9804819

Functional hierarchy between two OSE2 elements in the control of osteocalcin gene expression in vivo.

J L Frendo1, G Xiao, S Fuchs, R T Franceschi, G Karsenty, P Ducy.   

Abstract

Osteocalcin gene expression is initiated perinatally and is restricted to mature osteoblasts and odontoblasts. Because their pattern of expression is highly restricted, the osteocalcin genes are excellent tools to study osteoblast-specific gene expression. To define the mechanisms of osteocalcin cell-specific gene expression in vivo, we generated transgenic mice harboring deletion mutants of the promoter region of OG2, one of the mouse osteocalcin genes. We show here that only 647 base pairs of this promoter are sufficient to confer cell-specific and time-specific expression to a reporter gene in vivo. This promoter fragment contains two copies of OSE2. This osteoblast-specific cis-acting element binds Osf2, a recently characterized osteoblast-specific transcription factor (Ducy, P., Zhang, R., Geoffroy, V., Ridall, A. L., and Karsenty, G. (1997) Cell 89, 747-754). We also demonstrate that the proximal OSE2 element is critical to confer an osteoblast-specific, developmentally regulated pattern of expression to a reporter gene. The other OSE2 element, located more upstream and presenting a lower affinity for Osf2, affects only weakly OG2 promoter activity. These data demonstrate the crucial role of Osf2 in controlling osteocalcin gene expression. Since osteocalcin synthesis is a hallmark of the differentiated osteoblast phenotype, these results suggest that, beyond its developmental function, Osf2 is also required for the maintenance of the osteoblast phenotype postnatally.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9804819     DOI: 10.1074/jbc.273.46.30509

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  32 in total

1.  Misexpression of CCAAT/enhancer binding protein beta causes osteopenia.

Authors:  Stefano Zanotti; Lisa Stadmeyer; Anna Smerdel-Ramoya; Deena Durant; Ernesto Canalis
Journal:  J Endocrinol       Date:  2009-02-13       Impact factor: 4.286

2.  Tgfbr2 is required in osterix expressing cells for postnatal skeletal development.

Authors:  Sarah B Peters; Ying Wang; Rosa Serra
Journal:  Bone       Date:  2016-12-30       Impact factor: 4.398

3.  Effect of Cbfa1 on osteogenic differentiation of mesenchymal stem cells under hypoxia condition.

Authors:  Zhang-Hua Li; Wen Liao; Qiang Zhao; Tang Huan; Pan Feng; Xia Wei; Yang Yi; Ning-Sheng Shao
Journal:  Int J Clin Exp Med       Date:  2014-03-15

4.  Continuous expression of Cbfa1 in nonhypertrophic chondrocytes uncovers its ability to induce hypertrophic chondrocyte differentiation and partially rescues Cbfa1-deficient mice.

Authors:  S Takeda; J P Bonnamy; M J Owen; P Ducy; G Karsenty
Journal:  Genes Dev       Date:  2001-02-15       Impact factor: 11.361

5.  Glucocorticoids act directly on osteoclasts to increase their life span and reduce bone density.

Authors:  D Jia; C A O'Brien; S A Stewart; S C Manolagas; R S Weinstein
Journal:  Endocrinology       Date:  2006-08-24       Impact factor: 4.736

6.  A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development.

Authors:  P Ducy; M Starbuck; M Priemel; J Shen; G Pinero; V Geoffroy; M Amling; G Karsenty
Journal:  Genes Dev       Date:  1999-04-15       Impact factor: 11.361

7.  Impaired osteoblastic differentiation, reduced bone formation, and severe osteoporosis in noggin-overexpressing mice.

Authors:  Xue-Bin Wu; Yanan Li; Adina Schneider; Wanqin Yu; Gopalan Rajendren; Jameel Iqbal; Matsuo Yamamoto; Mohammad Alam; Lisa J Brunet; Harry C Blair; Mone Zaidi; Etsuko Abe
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

8.  Fhl2 deficiency results in osteopenia due to decreased activity of osteoblasts.

Authors:  Thomas Günther; Cecilia Poli; Judith M Müller; Philip Catala-Lehnen; Thorsten Schinke; Na Yin; Sandra Vomstein; Michael Amling; Roland Schüle
Journal:  EMBO J       Date:  2005-08-04       Impact factor: 11.598

9.  Primitive adult hematopoietic stem cells can function as osteoblast precursors.

Authors:  Elizabeth A Olmsted-Davis; Zbigniew Gugala; Fernando Camargo; Francis H Gannon; KathyJo Jackson; Kirsten Anderson Kienstra; H David Shine; Ronald W Lindsey; Karen K Hirschi; Margaret A Goodell; Malcolm K Brenner; Alan R Davis
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-12       Impact factor: 11.205

10.  Inhibition of osteoblastic bone formation by nuclear factor-kappaB.

Authors:  Jia Chang; Zhuo Wang; Eric Tang; Zhipeng Fan; Laurie McCauley; Renny Franceschi; Kunliang Guan; Paul H Krebsbach; Cun-Yu Wang
Journal:  Nat Med       Date:  2009-06       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.